Stay updated on HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page.
Latest updates to the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page
- Check7 days agoChange DetectedUI changes include showing the glossary, green highlights for additions and red highlights for deletions, and revision notes (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.4 is added to the record history, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check43 days agoChange DetectedThe history shows a new revision (v3.3.3) added and two items removed: HHS Vulnerability Disclosure and Revision: v3.3.2; these are site maintenance/versioning updates rather than trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check72 days agoChange DetectedThe page footer shows an updated site revision from v3.2.0 to v3.3.2, which appears to be a minor site version update with no impact on study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check79 days agoChange DetectedRemoved the government funding/operating-status notice that warned information on the site may not be up to date. The alert about potential delays and operating status has been deleted from the page.SummaryDifference0.8%
- Check93 days agoChange DetectedNo substantive changes were made in this version; the record shows only the earliest entry with no updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
Stay in the know with updates to HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page.